News, Events, Publications and Presentations

35 Items
14th May 2025

Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments
7th May 2025

Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL
7th May 2025

EASL 2025 YAQ005 + YAQ007: Transcriptomic and metabolic insights into hyperammonemia
7th May 2025

EASL 2025 YAQ005: Toll-like receptor 4 inhibition restores cytochrome C oxidase
7th May 2025

EASL 2025: YAQ007 Randomized, open-label, phase 2a comparator study
7th May 2025

EASL 2025 : YAQ001 positively impacts gut microbiome composition
21st Mar 2025

Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
21st Feb 2025

Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
11th Feb 2025

Yaqrit prepares phase 3 for ammonia scavenger in hepatic encephalopathy
1 2 3 4

Our Companies

Therapeutic for acute-on-chronic liver failure

Extracorporeal liver support for acute-on-chronic liver failure

Advanced microbiome therapeutic to restore gut health

Treatment and prevention of recurrence of hepatic encephalopathy